GEODE CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 80 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,560,159
-15.3%
1,487,794
+5.5%
0.00%
-50.0%
Q2 2023$13,656,214
-6.2%
1,410,766
+6.2%
0.00%0.0%
Q1 2023$14,564,239
+269858.1%
1,328,854
+6.4%
0.00%
+100.0%
Q4 2022$5,395
-99.9%
1,248,954
+3.6%
0.00%0.0%
Q3 2022$9,061,000
-22.5%
1,204,982
+3.6%
0.00%
-50.0%
Q2 2022$11,694,000
+743.1%
1,163,563
+938.0%
0.00%
Q1 2022$1,387,000
-42.0%
112,097
+7.2%
0.00%
Q4 2021$2,391,000
-12.2%
104,585
-15.0%
0.00%
Q3 2021$2,724,000
+51.2%
123,110
-11.5%
0.00%
Q2 2021$1,801,000
+8.6%
139,065
+8.8%
0.00%
Q1 2021$1,659,000
-6.2%
127,875
+1.1%
0.00%
Q4 2020$1,769,000
+3.7%
126,499
+9.1%
0.00%
Q3 2020$1,706,000
+7.3%
115,923
+18.4%
0.00%
Q2 2020$1,590,000
+14.3%
97,906
+2.0%
0.00%
Q1 2020$1,391,000
-55.1%
95,963
-37.3%
0.00%
Q4 2019$3,100,000
+793.4%
153,124
+135.6%
0.00%
Q3 2019$347,000
-18.7%
64,9850.0%0.00%
Q2 2019$427,000
+1.2%
64,9850.0%0.00%
Q1 2019$422,000
-52.4%
64,985
-50.0%
0.00%
Q4 2018$886,000
+105.6%
129,970
+100.0%
0.00%
Q3 2018$431,000
+18.1%
64,9850.0%0.00%
Q2 2018$365,000
+182.9%
64,985
+160.6%
0.00%
Q1 2018$129,000
+15.2%
24,9410.0%0.00%
Q4 2017$112,000
-28.2%
24,9410.0%0.00%
Q3 2017$156,000
+2.6%
24,9410.0%0.00%
Q2 2017$152,000
-18.7%
24,941
-2.6%
0.00%
Q1 2017$187,00025,6030.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders